3/26
04:15 pm
jazz
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Medium
Report
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
3/26
04:15 pm
jazz
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Medium
Report
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
3/26
09:12 am
jazz
Primrose Bio Launches Prima RNApols™ ExTend, an RNA Polymerase for Long-Template mRNA Manufacturing [Yahoo! Finance]
Medium
Report
Primrose Bio Launches Prima RNApols™ ExTend, an RNA Polymerase for Long-Template mRNA Manufacturing [Yahoo! Finance]
3/26
12:19 am
jazz
Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts [Yahoo! Finance]
Medium
Report
Is Jazz Pharmaceuticals plc (JAZZ) a Promising Biotech Stock According to Wall Street Analysts [Yahoo! Finance]
3/25
02:37 pm
jazz
Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
Low
Report
Why Jazz Pharmaceuticals (JAZZ) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
3/21
05:00 am
jazz
High Yields And Higher Returns: Inside The U.K. Cannabis Industry [Forbes]
Low
Report
High Yields And Higher Returns: Inside The U.K. Cannabis Industry [Forbes]
3/19
08:07 pm
jazz
Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect? [Yahoo! Finance]
Low
Report
Does Jazz (JAZZ) Have the Potential to Rally 38.94% as Wall Street Analysts Expect? [Yahoo! Finance]
3/19
07:52 am
jazz
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting [Yahoo! Finance]
3/19
07:30 am
jazz
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
Low
Report
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
3/14
12:08 pm
jazz
Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition? [Yahoo! Finance]
Low
Report
Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition? [Yahoo! Finance]
3/11
08:49 am
jazz
TSC Alliance® to Host 24th Annual Comedy for a Cure® on April 6 in Los Angeles [Yahoo! Finance]
Low
Report
TSC Alliance® to Host 24th Annual Comedy for a Cure® on April 6 in Los Angeles [Yahoo! Finance]
3/10
08:13 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at HC Wainwright from $200.00 to $217.00. They now have a "buy" rating on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at HC Wainwright from $200.00 to $217.00. They now have a "buy" rating on the stock.
3/7
12:54 pm
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $183.00 price target on the stock, up previously from $175.00.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $183.00 price target on the stock, up previously from $175.00.
3/7
08:17 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $179.00 price target on the stock, up previously from $145.00.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $179.00 price target on the stock, up previously from $145.00.
3/6
03:11 pm
jazz
Jazz expands in oncology with $935M deal for Chimerix [Yahoo! Finance]
Low
Report
Jazz expands in oncology with $935M deal for Chimerix [Yahoo! Finance]
3/6
10:55 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Truist Financial Co. from $220.00 to $230.00. They now have a "buy" rating on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target raised by analysts at Truist Financial Co. from $220.00 to $230.00. They now have a "buy" rating on the stock.
3/6
07:29 am
jazz
Health Care Roundup: Market Talk [Yahoo! Finance]
Low
Report
Health Care Roundup: Market Talk [Yahoo! Finance]
3/5
01:47 pm
jazz
https://seekingalpha.com/article/4764949-jazz-buys-chimerix-a-good-deal-to-make-with-major-approval-catalyst-in-play [Seeking Alpha]
Low
Report
https://seekingalpha.com/article/4764949-jazz-buys-chimerix-a-good-deal-to-make-with-major-approval-catalyst-in-play [Seeking Alpha]
3/5
11:57 am
jazz
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $210.00 price target on the stock.
Low
Report
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $210.00 price target on the stock.
3/5
07:46 am
jazz
M&A Snapshot: Jazz Pharmaceuticals acquires Chimerix at a 72% premium deal [Seeking Alpha]
Low
Report
M&A Snapshot: Jazz Pharmaceuticals acquires Chimerix at a 72% premium deal [Seeking Alpha]
3/5
07:07 am
jazz
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio [Yahoo! Finance]
3/5
07:00 am
jazz
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Low
Report
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
3/5
07:00 am
jazz
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
Low
Report
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
2/28
07:07 pm
jazz
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy? [Yahoo! Finance]
Low
Report
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy? [Yahoo! Finance]
2/28
10:43 am
jazz
International Markets and Jazz (JAZZ): A Deep Dive for Investors [Yahoo! Finance]
Low
Report
International Markets and Jazz (JAZZ): A Deep Dive for Investors [Yahoo! Finance]